InsiderTrades

Form 4 for SSNC SS&C Technologies Holdings Inc

Accepted 2026-05-22 16:41:35 ET · period of report 2026-05-20 · accession 0001193125-26-237074 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-05-22 16:41 2026-05-20+ SSNC ZAMKOW MICHAEL JAY Dir M - OptEx $30.45 +8,580 21.4K +67% +$261.2K
DM 2026-05-22 16:41 2026-05-20+ SSNC ZAMKOW MICHAEL JAY Dir S - Sale+OE $66.73 -6,000 18.4K -25% -$400.4K
DM 2026-05-22 16:41 2026-05-20+ SSNC ZAMKOW MICHAEL JAY Dir M - OptEx $0.00 -8,580 0 -100% $0
D 2026-05-22 16:41 2026-05-20 SSNC ZAMKOW MICHAEL JAY Dir A - Grant $0.00 +3,200 3,200 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-20 M A 3,000 $30.45 18,824 D — —
2 Common Common Stock 2026-05-20 S D 3,000 $66.78 15,824 D — — (F1) The price reported is the weighted average of the shares sold. The shares sold at varying prices in the range of $66.77 to $66.81. The reporting person undertakes, upon request by the Staff of the Securities and Exchange Commission, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2026-05-20 M A 2,580 — 18,404 D — — (F2) Reflects the vesting of restricted stock units granted to the reporting person on May 21, 2025, together with 33 dividend equivalent rights accrued thereon. (F2) Reflects the vesting of restricted stock units granted to the reporting person on May 21, 2025, together with 33 dividend equivalent rights accrued thereon. (F3) Restricted stock units convert into common stock on a one-for-one basis.
4 Common Common Stock 2026-05-22 M A 3,000 $30.45 21,404 D — —
5 Common Common Stock 2026-05-22 S D 3,000 $66.68 18,404 D — — (F8) The price reported is the weighted average of the shares sold. The shares sold at varying prices in the range of $66.63 to $66.70. The reporting person undertakes, upon request by the Staff of the Securities and Exchange Commission, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
6 Derivative Stock Option (right to buy) 2026-05-20 M D 3,000 $0.00 3,000 D $30.45 · — to 2026-05-25 3,000 Common Stock (F6) The stock option was fully vested as of the date of the grant.
7 Derivative Restricted Stock Units 2026-05-20 M D 2,580 $0.00 0 D — · — to — 2,580 Common Stock (F3) Restricted stock units convert into common stock on a one-for-one basis. (F2) Reflects the vesting of restricted stock units granted to the reporting person on May 21, 2025, together with 33 dividend equivalent rights accrued thereon. (F2) Reflects the vesting of restricted stock units granted to the reporting person on May 21, 2025, together with 33 dividend equivalent rights accrued thereon. (F2) Reflects the vesting of restricted stock units granted to the reporting person on May 21, 2025, together with 33 dividend equivalent rights accrued thereon. (F2) Reflects the vesting of restricted stock units granted to the reporting person on May 21, 2025, together with 33 dividend equivalent rights accrued thereon.
8 Derivative Restricted Stock Units 2026-05-20 A A 3,200 $0.00 3,200 D — · — to — 3,200 Common Stock (F3) Restricted stock units convert into common stock on a one-for-one basis. (F7) The restricted stock units vest 100% on the earlier of (i) the first anniversary of the grant date and (ii) the date of the issuer's annual general meeting of stockholders held in fiscal 2027. (F7) The restricted stock units vest 100% on the earlier of (i) the first anniversary of the grant date and (ii) the date of the issuer's annual general meeting of stockholders held in fiscal 2027. (F7) The restricted stock units vest 100% on the earlier of (i) the first anniversary of the grant date and (ii) the date of the issuer's annual general meeting of stockholders held in fiscal 2027.
9 Derivative Stock Option (Right to Buy) 2026-05-22 M D 3,000 $0.00 0 D $30.45 · — to 2026-05-25 3,000 Common Stock (F6) The stock option was fully vested as of the date of the grant.